Cancer research involves vast amounts of data, from genomic sequences to clinical trial results. Ransomware can jeopardize years of research by encrypting or deleting valuable data. This can delay the development of new treatments and therapies, ultimately affecting patient outcomes. In some cases, researchers may be forced to pay the ransom to regain access to their data, which can be a significant financial burden.
